Lung Cancer Research

Providence Thoracic Oncology Program emphasizes a multidisciplinary approach to cancer management.  Our clinical trials program offers a broad array of innovative clinical research, including studies of new surgical techniques, radiation, chemotherapy, targeted therapy and immunotherapy agents, and tissue banking.  Rachel E. Sanborn, M.D., specializes in thoracic oncology and clinical research, studying new agents or combinations in the treatment of lung cancer, mesothelioma and other thoracic tumors.

Dr. Sanborn serves as co-medical director of the Providence Thoracic Oncology Program as well as leading the Lung Cancer Research program at the Robert W. Franz Cancer Research Center. After graduating from Oregon Health & Science University with her medical degree, Dr. Sanborn completed her residency in internal medicine at the University of Illinois at Chicago.  She returned to Portland for her fellowship in hematology and medical oncology at Oregon Health & Science University.  She is board-certified in medical oncology and internal medicine.